Rab Prinjha: h-index, Total Citations, and Citation Map
Rab Prinjha's h-index is 77 (157 i10-index, 26,182+ total citations across 253+ publications) according to Google Scholar as of June 2026. Rab Prinjha is affiliated with Chief R&D Officer Curve Therapeutics.
Rab Prinjha is a researcher affiliated with Chief R&D Officer Curve Therapeutics, specializing in Epigenetics, Immunology, Oncology. Their work has been cited 26,182 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Rab Prinjha's Citation Metrics
Bibliometric impact based on 253 indexed publications.
- H-Index
- 77
- i10-Index
- 157
- Total Citations
- 26,182
- Citing Countries
- 10
As of June 2026.
Rab Prinjha has an h-index of 77 and 26,182 total citations across 253 publications, with research cited by institutions in 10 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Rab Prinjha's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 26,182 citations for Rab Prinjha
We've shown the most-cited 5,000. Unlock the full crawl (26,132 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Suppression of inflammation by a synthetic histone mimic
20101,863
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Rab Prinjha's research
Rab Prinjha is a researcher in Epigenetics, Immunology and Oncology at Chief R&D Officer Curve Therapeutics. Their work has been cited 26,182 times across 253 publications (h-index 77), according to Google Scholar.
Their most-cited work, “Suppression of inflammation by a synthetic histone mimic” (2010), has accumulated 1,863 citations. Other influential works include “Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia” (2011) with 1,857 citations and “Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways” (2008) with 1,181 citations.
Citations of Rab Prinjha's research come primarily from United States, Germany and Canada, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
